Asshat refuses to show any proof of his work other than a glaucoma patent app that’s now losing it’s luster...compared to the more advanced glaucoma tech out there
Dilution will definitely happen and will most likely be in the form of a toxic loan...because no reputable company wants to play with inmed anymore
Isn’t that right martin bott? He ditched out- good sign biosynth is a shit show under adams direction
Doctors bailing- sign that their IP is a shit show
BUT, the insiders sure do hold a lot of shit show shares and the next inevitable bogus pump will create a nice exit. Really, that’s all there is to be sure about here
News 
Market Data 
Discover 
